ANI Pharmaceuticals (ANIP) News Today $95.60 -1.19 (-1.22%) As of 01:51 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock ANIP Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent September 2025 August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 Time Period Q3 EPS Forecast for ANI Pharmaceuticals Raised by AnalystSeptember 19 at 6:51 AM | marketbeat.comQ3 EPS Estimate for ANI Pharmaceuticals Boosted by AnalystSeptember 19 at 2:15 AM | americanbankingnews.comANI Pharmaceuticals (NASDAQ:ANIP) Price Target Raised to $121.00September 18, 2025 | marketbeat.comHC Wainwright Forecasts Strong Price Appreciation for ANI Pharmaceuticals (NASDAQ:ANIP) StockSeptember 18, 2025 | americanbankingnews.comANI Pharmaceuticals price target raised to $121 from $93 at H.C. WainwrightSeptember 17, 2025 | msn.comInsider Selling: ANI Pharmaceuticals (NASDAQ:ANIP) VP Sells 400 Shares of StockSeptember 16, 2025 | marketbeat.comANI Pharmaceuticals (NASDAQ:ANIP) VP Sells $39,368.00 in StockSeptember 16, 2025 | insidertrades.comWoodline Partners LP Makes New $11.14 Million Investment in ANI Pharmaceuticals, Inc. $ANIPSeptember 14, 2025 | marketbeat.comShould ANI Pharmaceuticals’ (ANIP) Ambitious 2025 Revenue Forecast Prompt Action From Investors?September 13, 2025 | finance.yahoo.comANI Pharmaceuticals, Inc. $ANIP Shares Sold by Great Lakes Advisors LLCSeptember 12, 2025 | marketbeat.comANI Pharmaceuticals (NASDAQ:ANIP) Sets New 1-Year High on Analyst UpgradeSeptember 11, 2025 | marketbeat.comANI Pharmaceuticals (NASDAQ:ANIP) Hits New 12-Month High on Analyst UpgradeSeptember 11, 2025 | americanbankingnews.comANI Pharmaceuticals (NASDAQ:ANIP) Price Target Raised to $114.00 at GuggenheimSeptember 10, 2025 | marketbeat.comMillennium Management LLC Sells 184,508 Shares of ANI Pharmaceuticals, Inc. $ANIPSeptember 10, 2025 | marketbeat.comANI Pharmaceuticals, Inc. (ANIP) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference TranscriptSeptember 9, 2025 | seekingalpha.comFederation des caisses Desjardins du Quebec Has $1.63 Million Holdings in ANI Pharmaceuticals, Inc. $ANIPSeptember 9, 2025 | marketbeat.comComerica Bank Has $773,000 Stake in ANI Pharmaceuticals, Inc. $ANIPSeptember 9, 2025 | marketbeat.comANI Pharmaceuticals price target raised to $114 from $86 at GuggenheimSeptember 8, 2025 | msn.com4 Analysts Have This To Say About ANI PharmaceuticalsSeptember 8, 2025 | benzinga.comParkman Healthcare Partners LLC Acquires Shares of 105,000 ANI Pharmaceuticals, Inc. $ANIPSeptember 8, 2025 | marketbeat.comNorthern Trust Corp Acquires 12,517 Shares of ANI Pharmaceuticals, Inc. $ANIPSeptember 6, 2025 | marketbeat.comANI Pharmaceuticals (NASDAQ:ANIP) Director Antonio Pera Sells 7,292 SharesSeptember 5, 2025 | insidertrades.comAYAL Capital Advisors Ltd Acquires Shares of 66,715 ANI Pharmaceuticals, Inc. $ANIPSeptember 5, 2025 | marketbeat.comANI Pharmaceuticals (NASDAQ:ANIP) Sets New 12-Month High - Still a Buy?September 4, 2025 | marketbeat.comRaymond James Financial Inc. Increases Stake in ANI Pharmaceuticals, Inc. $ANIPSeptember 4, 2025 | marketbeat.comANI Pharmaceuticals, Inc. (NASDAQ:ANIP) Given Average Rating of "Buy" by AnalystsSeptember 4, 2025 | marketbeat.comANI Pharmaceuticals, Inc. $ANIP Shares Purchased by Nomura Holdings Inc.September 3, 2025 | marketbeat.comWellington Management Group LLP Purchases New Position in ANI Pharmaceuticals, Inc. $ANIPSeptember 3, 2025 | marketbeat.comANI Pharmaceuticals, Inc. $ANIP Shares Sold by American Century Companies Inc.September 3, 2025 | marketbeat.comApis Capital Advisors LLC Acquires New Position in ANI Pharmaceuticals, Inc. $ANIPSeptember 2, 2025 | marketbeat.comANI Pharmaceuticals, Inc. (ANIP) Hits Milestone with Cortrophin Gel Prefilled Syringe LaunchSeptember 2, 2025 | finance.yahoo.comGeneric Pharmaceuticals Stocks Q2 Earnings: ANI Pharmaceuticals (NASDAQ:ANIP) Best of the BunchSeptember 2, 2025 | finance.yahoo.comWalleye Capital LLC Sells 40,725 Shares of ANI Pharmaceuticals, Inc. $ANIPAugust 31, 2025 | marketbeat.comJump Financial LLC Makes New $1.56 Million Investment in ANI Pharmaceuticals, Inc. $ANIPAugust 31, 2025 | marketbeat.comNuveen LLC Acquires Shares of 48,601 ANI Pharmaceuticals, Inc. $ANIPAugust 31, 2025 | marketbeat.comInsider Selling: ANI Pharmaceuticals (NASDAQ:ANIP) SVP Sells 1,763 Shares of StockAugust 27, 2025 | marketbeat.comVirtus Advisers LLC Takes $922,000 Position in ANI Pharmaceuticals, Inc. $ANIPAugust 27, 2025 | marketbeat.comANI Pharmaceuticals, Inc. $ANIP Stock Holdings Boosted by Hotchkis & Wiley Capital Management LLCAugust 27, 2025 | marketbeat.comANI Pharmaceuticals (NASDAQ:ANIP) Director Sells $229,087.36 in StockAugust 27, 2025 | insidertrades.comStonepine Capital Management LLC Has $3.21 Million Stock Holdings in ANI Pharmaceuticals, Inc. $ANIPAugust 26, 2025 | marketbeat.comPenn Capital Management Company LLC Invests $448,000 in ANI Pharmaceuticals, Inc. $ANIPAugust 26, 2025 | marketbeat.comKrista Davis Sells 1,763 Shares of ANI Pharmaceuticals (NASDAQ:ANIP) StockAugust 26, 2025 | insidertrades.comVanguard Group Inc. Sells 132,901 Shares of ANI Pharmaceuticals, Inc. $ANIPAugust 26, 2025 | marketbeat.comANI Pharmaceuticals to Present at Upcoming Investor ConferencesAugust 25, 2025 | globenewswire.comANI Pharmaceuticals (NASDAQ:ANIP) Upgraded to "Strong-Buy" at Zacks ResearchAugust 25, 2025 | marketbeat.comQuantbot Technologies LP Takes $1.31 Million Position in ANI Pharmaceuticals, Inc. $ANIPAugust 25, 2025 | marketbeat.comAdvantage Alpha Capital Partners LP Increases Stake in ANI Pharmaceuticals, Inc. $ANIPAugust 24, 2025 | marketbeat.comANI Pharmaceuticals (NASDAQ:ANIP) COO Muthusamy Shanmugam Sells 47,012 SharesAugust 23, 2025 | insidertrades.com1 Mooning Stock for Long-Term Investors and 2 That UnderwhelmAugust 22, 2025 | finance.yahoo.comANI Pharmaceuticals (NASDAQ:ANIP) Sets New 1-Year High - Time to Buy?August 22, 2025 | marketbeat.com Get ANI Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for ANIP and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. ANIP Media Mentions By Week ANIP Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ANIP News Sentiment▼0.950.73▲Average Medical News Sentiment ANIP News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ANIP Articles This Week▼137▲ANIP Articles Average Week Get the Latest News and Ratings for ANIP and Related Stocks Enter your email address to receive the latest news and analysts' ratings for ANI Pharmaceuticals and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies ADMA Biologics News Annovis Bio News Grifols News Rhythm Pharmaceuticals News Abivax News Cytokinetics News Legend Biotech News Axsome Therapeutics News Nuvalent News Avidity Biosciences News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:ANIP) was last updated on 9/22/2025 by MarketBeat.com Staff From Our PartnersWhat The Silver Boom Could Mean For You…AI, electric vehicles, and even global central banks are quietly fueling record demand for silver. This once-o...Goldco Precious Metals | SponsoredTrump’s Plan May Undo 1933’s Biggest Financial InjusticeTrump's Reset Can Give Birth To America's Greatest Era Yet A 90-Year cycle may end soon, creating real weal...American Hartford Gold | SponsoredWhy More Investors Are Using Family Trusts to Protect Their WealthFor many investors, a family trust can be an essential tool for protecting assets, avoiding probate, and ensur...SmartAsset | SponsoredRecession Risk: 90% — Are Your Savings Ready?Moody's latest report shows one-third of U.S. economic activity is already in recession or at high risk.Lear Capital | SponsoredIRS Wants Another Check on Sept 15th—What If You Could Keep It Instead?On September 15th, the IRS collects another round of quarterly tax payments—targeting self-employed profession...American Alternative | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredTrump’s new nightmare beginsPorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredPrepare for the “Mar-a-Lago Accord” Money ShockWhy Are Wall Street Insiders Moving Their Money to This ONE Asset? Something far more consequential for you...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ANI Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share ANI Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
